Christopher Frampton
About
In The Last Decade
Christopher Frampton
332 papers receiving 14.7k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Cardiology and Cardiovascular Medicine 4.2k
- Surgery 3.1k
- Epidemiology 1.9k
- Pulmonary and Respiratory Medicine 1.8k
- Clinical Psychology 1.7k
Countries citing papers authored by Christopher Frampton
This map shows the geographic impact of Christopher Frampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Frampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Frampton more than expected).
Fields of papers citing papers by Christopher Frampton
This network shows the impact of papers produced by Christopher Frampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Frampton. The network helps show where Christopher Frampton may publish in the future.
Co-authorship network of co-authors of Christopher Frampton
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Frampton. A scholar is included among the top collaborators of Christopher Frampton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Frampton. Christopher Frampton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 42 | |
| 6 | 2 | |
| 7 | 26 | |
| 8 | 33 | |
| 9 | 14 | |
| 10 | 9 | |
| 11 | Pilot study of methods for assessing unmet secondary health care need in New Zealand. | 5 |
| 12 | Improved scores for observed teamwork in the clinical environment following a multidisciplinary operating room simulation intervention. | 16 |
| 13 | 67 | |
| 14 | 52 | |
| 15 | 55 | |
| 16 | 17 | |
| 17 | Development of a routine outcome monitoring instrument for use with clients in the New Zealand Alcohol and Other Drug treatment sector: the Alcohol and Drug Outcome Measure (ADOM) | 12 |
| 18 | Assessing Emotional and Behavioural Problems in Children: Factors Associated with Multiple Informant Consistency in New Zealand | 9 |
| 19 | 95 | |
| 20 | Abstract 343: Coenzyme Q10 does not Improve Simvastatin Tolerability in Dyslipidemic Patients with Prior Statin-Induced Myalgia | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.